Study Design and Rationale of Heroic-pkp2: a Phase 1/2 Study of the Safety and Efficacy of Lx2020 Gene Therapy in Patients With Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant